Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

NASDAQ:AEYE - Nasdaq - US0507342014 - Common Stock - Currency: USD

20.2375  +0.24 (+1.19%)

Fundamental Rating

2

Overall AEYE gets a fundamental rating of 2 out of 10. We evaluated AEYE against 284 industry peers in the Software industry. AEYE may be in some trouble as it scores bad on both profitability and health. AEYE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AEYE has reported negative net income.
In the past year AEYE had a positive cash flow from operations.
AEYE had negative earnings in each of the past 5 years.
AEYE had negative operating cash flow in 4 of the past 5 years.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

AEYE has a Return On Assets of -11.22%. This is in the lower half of the industry: AEYE underperforms 61.01% of its industry peers.
Looking at the Return On Equity, with a value of -44.87%, AEYE is doing worse than 68.59% of the companies in the same industry.
Industry RankSector Rank
ROA -11.22%
ROE -44.87%
ROIC N/A
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1K -2K -3K

1.3 Margins

AEYE has a better Gross Margin (78.87%) than 76.53% of its industry peers.
AEYE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEYE has been increased compared to 1 year ago.
AEYE has more shares outstanding than it did 5 years ago.
AEYE has a worse debt/assets ratio than last year.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 2.91 indicates that AEYE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AEYE's Altman-Z score of 2.91 is in line compared to the rest of the industry. AEYE outperforms 49.82% of its industry peers.
AEYE has a debt to FCF ratio of 8.98. This is a slightly negative value and a sign of low solvency as AEYE would need 8.98 years to pay back of all of its debts.
AEYE's Debt to FCF ratio of 8.98 is in line compared to the rest of the industry. AEYE outperforms 50.90% of its industry peers.
AEYE has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.24, AEYE is not doing good in the industry: 79.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.98
Altman-Z 2.91
ROIC/WACCN/A
WACC10.84%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

AEYE has a Current Ratio of 0.84. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.84, AEYE is not doing good in the industry: 80.51% of the companies in the same industry are doing better.
AEYE has a Quick Ratio of 0.84. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.84, AEYE is doing worse than 80.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.45% over the past year.
AEYE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.92%.
The Revenue has been growing by 40.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)56.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Sales Q2Q%13.87%

3.2 Future

The Earnings Per Share is expected to grow by 32.17% on average over the next years. This is a very strong growth
AEYE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.52% yearly.
EPS Next Y53.79%
EPS Next 2Y45.2%
EPS Next 3Y32.17%
EPS Next 5YN/A
Revenue Next Year12.27%
Revenue Next 2Y16.56%
Revenue Next 3Y17.52%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AEYE. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 381.55, AEYE can be considered very expensive at the moment.
62.45% of the companies in the same industry are cheaper than AEYE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, AEYE is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 381.55
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as AEYE.
Industry RankSector Rank
P/FCF 242.13
EV/EBITDA N/A
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AEYE does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as AEYE's earnings are expected to grow with 32.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.2%
EPS Next 3Y32.17%

0

5. Dividend

5.1 Amount

No dividends for AEYE!.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (2/5/2025, 9:33:48 AM)

20.2375

+0.24 (+1.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners25.29%
Inst Owner Change-1.75%
Ins Owners46.06%
Ins Owner Change0.2%
Market Cap246.49M
Analysts82
Price Target33.35 (64.79%)
Short Float %9.96%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-1.51%
Revenue beat(4)0
Avg Revenue beat(4)-1.78%
Min Revenue beat(4)-2.48%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)0
Avg Revenue beat(12)-1.66%
Revenue beat(16)0
Avg Revenue beat(16)-1.69%
PT rev (1m)-5.56%
PT rev (3m)14.74%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)400.3%
EPS NY rev (1m)0.22%
EPS NY rev (3m)-67.55%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)6.38%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 381.55
P/S 7.39
P/FCF 242.13
P/OCF 82.05
P/B 33.53
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)0.05
Fwd EY0.26%
FCF(TTM)0.08
FCFY0.41%
OCF(TTM)0.25
OCFY1.22%
SpS2.74
BVpS0.6
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.22%
ROE -44.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.87%
FCFM 3.05%
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.98
Debt/EBITDA N/A
Cap/Depr 84.08%
Cap/Sales 5.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 2.91
F-Score5
WACC10.84%
ROIC/WACCN/A
Cap/Depr(3y)91.08%
Cap/Depr(5y)91.73%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y53.79%
EPS Next 2Y45.2%
EPS Next 3Y32.17%
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Sales Q2Q%13.87%
Revenue Next Year12.27%
Revenue Next 2Y16.56%
Revenue Next 3Y17.52%
Revenue Next 5YN/A
EBIT growth 1Y64.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.31%
EBIT Next 3Y53.25%
EBIT Next 5YN/A
FCF growth 1Y112.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.91%
OCF growth 3YN/A
OCF growth 5YN/A